• Uncategorized

SGLT2 Inhibitors Tied to Lower Risk in Patients with Diabetes and Cirrhosis

A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2 inhibitors offer superior multi-organ protection…